MedCity News

JANUARY 12, 2025

Other STAT6 drug developers include Kymera Therapeutics and Sanofi-partnered Recludix Pharma, which is presenting this week during the J.P. Gilead Sciences is acquiring LEO Pharmas oral small molecule inhibitors of STAT6, a protein key to two validated inflammation pathways. Morgan Healthcare Conference.

Pharma 260

Pharma Healthcare Healthcare Biopharma 260

MedCity News

NOVEMBER 5, 2024

A different Beam program in preclinical development could avoid the need for toxic preconditioning; data from both programs will be presented during the upcoming American Society of Hematology annual meeting.

Medicine 273

Medicine Biopharma Pharma 273

MedCity News

NOVEMBER 4, 2024

Higher doses of a Viking Therapeutics pill that targets two receptors led to greater weight loss without worsening safety or tolerability, according to Phase 1 results presented during the ObesityWeek conference. Meanwhile, an injectable version of this Viking drug is on track to Phase 3 testing.

Safety 277

Safety Biopharma 277

PM360

DECEMBER 20, 2024

Established in 2012, PM360 introduced the first-ever issue focused entirely on our industrys latest innovations. Categories explore every sector of the healthcare industry, from life sciences to marketing. PM360 would like to welcome you to the new age of innovation with our illuminating Innovations Issue.

Marketing 100

Marketing Healthcare Healthcare Media 100

MedCity News

DECEMBER 5, 2024

Healthcare needs a better way to collect information from all sources, organize it, summarize it and present it to providers in a way that lets them deliver the necessary treatment, confident that the material is sound and verifiable. The post How the Right AI Can Improve Health Risk Assessments appeared first on MedCity News.

Healthcare 300

Healthcare Healthcare Physicians Patients 300

Fierce Pharma

OCTOBER 30, 2024

As part of the new budget presented Wednesday by the U.K.’s Biopharma production efforts are set to receive a big boost in the U.K. thanks to a new budget rolled out by the Labour Party following this summer’s general election. |

Manufacturing 209

Manufacturing Biopharma Medical 209

MedCity News

JANUARY 8, 2024

The word has gained greater urgency in recent years as the consumer trend in healthcare has forced payers, providers and all other kinds of healthcare stakeholders to swear by it.

Healthcare 300

Healthcare Healthcare Retail Biopharma 300

Fierce Pharma

JUNE 14, 2024

Six months after Vertex earned a historic FDA approval for sickle cell d | Six months after Vertex earned a historic FDA approval for sickle cell disease (SCD) gene therapy Casgevy (exa-cel), long-term data is beginning to show the consistent efficacy and durability of the treatment, which is the first ever to be developed using CRISPR gene editing (..)

FDA 246

FDA 246

MedCity News

JULY 20, 2023

By reimagining health care supply chain as a centralized, high-value distribution and product selection and procurement model, hospitals and health systems can more effectively reach their goals for expense reduction while driving substantial improvements for patients and team members alike.

Distribution 246

Distribution Patients Management 246

MedCity News

AUGUST 26, 2024

With so much hinging on technology that is the subject of so much hype, it is important to understand where AI actually helps at present — and where it most definitely does not. The post The Truth About AI and Healthcare Payer Modernization appeared first on MedCity News.

Healthcare 307

Healthcare Healthcare 307

MedCity News

JUNE 16, 2024

Palliative care provided by video was equivalent to in-person visits with a clinician, according to study results presented during the recent annual meeting of the American Society of Clinical Oncology. Investigators say these results indicate telehealth can make palliative care accessible to more cancer patients.

Patients 322

Patients Biopharma 322

MedCity News

SEPTEMBER 10, 2023

Some of the use cases the EHR vendor is exploring include an enhanced search and summarization tool that would present clinicians with a longitudinal view of their patient and a tool that would generate predictive summaries of what a patient’s stay might look like at the time of admission.

Patients 358

Patients Healthcare Healthcare 358

PharmaVoice

MARCH 10, 2025

Experts say cost and other barriers present challenges to returning to U.S.

Manufacturing 238

Manufacturing Pharma 238

MedCity News

NOVEMBER 16, 2022

The findings were presented at the HLTH conference in Las Vegas. Because of bad digital experiences, 41% of patients have changed providers, the Notable survey discovered.

Patients 307

Patients Medical 307

MedCity News

JUNE 29, 2022

Mona Flores, Global Head of Medical AI at Nvidia, will deliver the keynote talk kicking off the MedCity INVEST Digital Health conference, scheduled for Wednesday, September 28, in Dallas and presented in collaboration with Health Wildcatters. Register today.

Healthcare 318

Healthcare Healthcare Medical 318

MedCity News

JUNE 2, 2024

The results will be presented Sunday during the annual meeting of the American Society of Clinical Oncology. AstraZeneca’s Tagrisso and Imfinzi helped patients live longer in separate pivotal clinical trials evaluating the drugs in two different types of lung cancer.

Patients 306

Patients Biopharma Pharma 306

Fierce Pharma

OCTOBER 22, 2024

Activist investor Starboard Value is baring its teeth at Pfizer management, more openly going after CEO Albert Bourla’s job in a new presentation. Activist investor Starboard Value is baring its teeth at Pfizer management, more openly going after CEO Albert Bourla’s job.

Management 290

Management 290

MedCity News

JUNE 12, 2024

More details will be presented at a medical conference this week. Avidity Biosciences’ RNA therapy for facioscapulohumeral muscular dystrophy has preliminary clinical data showing it knocked down expression of a gene that causes this rare disease.

Medical 300

Medical Biopharma Pharma 300

MedCity News

JANUARY 5, 2024

Check out news from Kismet Health, the University of California at Berkeley’s life science startups, and the companies presenting at the Consumer Technology Association’s pitch contest at CES.

Healthcare 307

Healthcare Healthcare 307

MedCity News

AUGUST 5, 2024

Detailed results will be presented during the European Society of Cardiology annual meeting in September. Bayer reported a Phase 3 test of Kerendia in heart failure led to statistically significant reductions in cardiovascular death and hospitalizations.

Biopharma 299

Biopharma Pharma 299

MedCity News

JULY 19, 2024

It also explores the ethical issues AI in healthcare presents. A new eBook from MedCity News highlights the variety of technologies emerging from AI tech developers across the healthcare landscape from health tech startups to healthcare organizations, biopharma companies, and a medtech giant.

Ethics 293

Ethics Biopharma Healthcare Healthcare 293

MedCity News

APRIL 4, 2024

However, LLMs also present significant challenges associated with privacy and bias that also must be considered. LLMs bring great potential to help the healthcare industry center care around patients’ needs by improving communication, access, and engagement.

Patients 290

Patients Healthcare Healthcare 290

MedCity News

SEPTEMBER 21, 2023

During a conference presentation on Tuesday, healthcare AI expert Suchi Saria laid out seven AI pitfalls hospitals should look out for — some of these include being duped by Big Tech companies’ marketing strategies and focusing too much on administrative use cases.

Healthcare 326

Healthcare Healthcare Marketing 326

MedCity News

AUGUST 12, 2024

Merck is acquiring a Curon Biopharmaceuticals drug whose encouraging Phase 1 data were presented during the ASCO annual meeting. The pharmaceutical giant sees potential applications of the bispecific antibody in cancer and autoimmune disease.

Pharmaceutical 284

Pharmaceutical Biopharma Pharma 284

MedCity News

JANUARY 9, 2023

In an interview with MedCity News after his presentation at the J.P. Morgan Healthcare Conference, Wright Lassiter III said while some providers will be considered commodities, his vision for CommonSpirit Health is not to be “at the bottom of the totem pole.”

Healthcare 301

Healthcare Healthcare 301

MedCity News

OCTOBER 27, 2023

Seven companies presented their approaches to addressing women’s health. Femtech was the theme of the INVEST Digital Health Pitch Perfect contest in Dallas this week.

284

284

MedCity News

JUNE 2, 2024

The results were presented Sunday during the annual meeting of the America Society of Clinical Oncology. GSK’s Blenrep has pivotal clinical trial results showing the multiple myeloma therapy reduced the risk of disease progression or death by nearly 50%.

Marketing 283

Marketing Biopharma Pharma 283

MedCity News

APRIL 17, 2024

In addition to panel discussions around some of the hottest topics in healthcare transformation, there is also a startup pitch contest, a presentation on government funding for startups and networking opportunities. The post Want to Connect with Innovative Healthcare Startups and Investors? Register for MedCity INVEST Today!

Healthcare 274

Healthcare Healthcare Government Networking 274

Fierce Pharma

JULY 31, 2024

On the heels of game-changing trial results presented at la | On the heels of game-changing trial results presented at last year's ASH meeting, J&J is introducing what it calls a "foundational frontline therapy" in multiple myeloma and at the same time expanding its already impressive presence in the field.

FDA 228

FDA 228

MedCity News

APRIL 4, 2024

In addition to panel discussions around some of the hottest topics in healthcare transformation, there is also a startup pitch contest, a presentation on government funding for startups and networking opportunities. The MedCity INVEST conference is scheduled for May 21-22 at the Ritz Carlton hotel in Chicago.

Government 284

Government Healthcare Healthcare Networking 284

MedCity News

MARCH 15, 2024

The new financing will support clinical trial plans, but first, preclinical proof-of-concept data will be presented during the American Association for Cancer Research annual meeting. Tubulis’s next-generation ADC cancer drugs are designed to overcome limitations of currently available therapies in this drug class.

Biopharma 293

Biopharma Pharma 293

MedCity News

MAY 22, 2024

The deal comes just prior to the scheduled presentation of clinical data in two of them. Biogen’s acquisition of Human Immunology Biosciences brings a drug candidate with potential applications in multiple immune-mediated disorders.

Biopharma 266

Biopharma Pharma 266

Fierce Pharma

OCTOBER 30, 2024

To hear GSK CEO Emma Walmsley tell it, the third quarter presented “some challenges” for the drugmaker. | To hear GSK CEO Emma Walmsley tell it, the third quarter presented “some challenges” for the British drugmaker.

Sales 220

Sales 220

Fierce Pharma

AUGUST 8, 2024

As Novavax presented its quarterly earnings, finance chief Jim Kelly said the company was “actively exploring” the sale of its manufacturing facility in the Czech Republic. It was 2020 and Maryland biotech Novavax was thinking big. It had a plan to become a COVID vaccine powerhouse, with enough manufacturing capacity to supply the U.S. |

Manufacturing 297

Manufacturing Sales Government 297

MedCity News

FEBRUARY 14, 2024

2024 presents an exciting yet challenging landscape for global pharma marketers.

Marketing 283

Marketing Pharma Pharmaceutical Patients 283

MedCity News

NOVEMBER 9, 2022

Marley Drug, a competitor, said its company has not experienced delays and presented itself as an alternative for Americans. A customer of Cost Plus Drugs received an email from the company in October stating that “due to skyrocketing demand,” shipping times have been delayed.

Prescription 284

Prescription 284

MedCity News

JULY 9, 2024

Achieving true national interoperability requires that all constituents have access to information that is trustworthy, accurate and presented in a way that is usable and actionable. The post The Healthcare Interoperability Road Trip – “Are We There Yet?” appeared first on MedCity News.

Healthcare 255

Healthcare Healthcare 255